The cardiovascular effects of pancuronium bromide during halothane anaesthesia

[1]  D. Trop,et al.  The use of pancuronium bromide--a steroidal neuromuscular blocking agent--in prolonged operations. , 1971, Anesthesia and analgesia.

[2]  A. Dobkin,et al.  Pancuronium bromide (Pavulon®) evaluation of its clinical pharmacology , 1971, Canadian Anaesthetists' Society journal.

[3]  R. Katz.  Clinical Neuromuscular Pharmacology of Pancuronium , 1971, Anesthesiology.

[4]  G. R. Kelman,et al.  Cardiovascular effects of pancuronium in man. , 1971, British journal of anaesthesia.

[5]  I. Bonta,et al.  Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. , 1970, European journal of pharmacology.

[6]  J. Nunn,et al.  Applied respiratory physiology with special reference to anaesthesia , 1969 .

[7]  D. B. Ellis,et al.  PROCEEDINGS OF THE ANAESTHETIC RESEARCH GROUP EDINBURGH MEETING: JULY 1, 1967: Abstracts of work completed and in progress , 1967 .

[8]  G. R. Kelman,et al.  CIRCULATORY INFLUENCES OF ARTIFICIAL VENTILATION DURING NITROUS OXIDE ANAESTHESIA IN MAN II: RESULTS: THE RELATIVE INFLUENCE OF MEAN INTRATHORACIC PRESSURE AND ARTERIAL CARBON DIOXIDE TENSION , 1967 .

[9]  N. T. Smith,et al.  Hemodynamic effects of gallamine and tubocurarine administered during halothane anesthesia. , 1967, JAMA.

[10]  J. Michenfelder,et al.  Effect of Hypocapnia on Cardiac Output During Anesthesia , 1966, Anesthesiology.

[11]  R. Neill,et al.  HALOTHANE AND TUBOCURARINE. A STUDY OF CHANGES IN BLOOD PRESSURE , 1966 .

[12]  R. Neill,et al.  Halothane and tubocurarine , 1965 .